There are several important considerations that should be addressed early when building a medical products company, but they are often postponed until after a Series A financing. Join Chris Porter as he explores these frequently overlooked issues and offers practical guidance for investors on how to navigate them before they become larger challenges.
Date: Wednesday, July 29th
Location: The Meydenbauer Center or via livestream
Time: 10:30–11:30am (before the AoA member meeting)